National Commission on Certification of Physician Assistants. Becoming Certified [Web page]. Available at: https://www.nccpa.net/BecomingCertified. Accessed May 6, 2018.
10.
National Commission on Certification of Physician Assistants. Maintaining Certification [Web page]. Available at: https://www.nccpa.net/CertificationProcess. Accessed May 6, 2018.
American Psychiatric Association.Substance-Related and Addictive Disorders. Fifth ed. In: Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Association; 2013:481–590.
13.
FriedmannPD. Alcohol use in adults. N Engl J Med.2013;368(4):365–373.
14.
SiqueiraL, SmithVC, Committee on substance abuse. Binge drinking. Pediatrics.2015;136(3):e718–e726.
15.
National Academies of Sciences, E and M.The Health Effects of Cannabis and Cannabinoids.Washington, DC: National Academies Press; 2017.
16.
McCabeSE, BoydCJ, TeterCJ. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend.2009;102(1–3):63–70.
17.
VolkowND, McLellanAT. Opioid Abuse in Chronic Pain-Misconceptions and Mitigation Strategies. N Engl J Med.2016;374(13):1253–1263.
18.
DartRC, SurrattHL, CiceroTJ. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med.2015;372(3):241–248.
19.
CiceroTJ, EllisMS, SurrattHL, KurtzSP. The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years. JAMA Psychiatry.2014;71(7):821–826.
20.
BoydCJ, CranfordJA, McCabeSE. Longitudinal Trajectories of Non-Medical Use of Prescription Medication Among Middle and High School Students. J Addict Dis.2016;35(4):258–265.
21.
BachhuberMA, HennessyS, CunninghamCO, StarrelsJL. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013. Am J Public Health.2016;106(4):686–688.
22.
SweeneyCT, SembowerMA, ErtischekMD, ShiffmanS, SchnollSH. Nonmedical Use of Prescription ADHD Stimulants and Preexisting Patterns of Drug Abuse. J Addict Dis.2013;32(1):1–10.
23.
RombergAR, Miller LoEM, CucciaAF, . Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013–2018. Drug Alcohol Depend.2019;203(19):1.
24.
SinhaS, ShahA. Pharmacotherapy of Tobacco Use Disorder. Am J Psychiatry Resid J.2016;11(9):8–12.
25.
Center for Behavioral Health Statistics and Quality. Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). 2016. http://www.samhsa.gov/data/
SchuckitM. A brief history of research on the genetics of alcohol and other drug use disorders. J Stud Alcohol Drugs Suppl.2014;75(supplement17):59–67.
29.
HingsonRW, HeerenT, WinterMR. Age at Drinking Onset and Alcohol Dependence: Age at Onset, Duration, and Severity. Arch Pediatr Adolesc Med.2006;160(7):739–746.
30.
McCabeSE, WestBT, MoralesM, CranfordJA, BoydCJ. Does Early Onset of Non-Medical Use of Prescription Drugs Predict Subsequent Prescription Drug Abuse and Dependence? Results From a National Study. Addiction.2007;102(12):1920–1930.
31.
KilpatrickDG, AciernoR, SaundersB, ResnickHS, BestCL, SchnurrPP. Risk Factors for Adolescent Substance Abuse and Dependence: Data From a National Sample. J Consult Clin Psychol.2000;68(1):19–30.
32.
SullivanMD, EdlundMJ, ZhangL, UnutzerJ, WellsKB. Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use. Arch Intern Med.2006;166(19):2087–2093.
33.
GroenmanAP, JanssenTWP, OosterlaanJ. Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis. J Am Acad Child Adolesc Psychiatry.2017;56(7):556–569.
34.
VolkowND, KoobGF, McLellanAT. Neurobiologic Advances From the Brain Disease Model of Addiction. N Engl J Med.2016;374(4):363–371.
35.
KoobGF, VolkowND. Neurobiology of Addiction: A Neurocircuitry Analysis. Lancet Psych.2016;3(8):760–773.
36.
ShieldKD, ParryC, RehmJ. Chronic Diseases and Conditions Related to Alcohol Use. Alcohol Res.2014;35(2):155–171.
37.
VolkowND, BalerRD, ComptonWM, WeissS. Adverse health effects of marijuana use. N Engl J Med.2014;370(23):2219–2227.
38.
CroffordLJ. Adverse Effects of Chronic Opioid Therapy for Chronic Musculoskeletal Pain. Nat Rev Rheumatol.2010;6(4):191–197.
39.
UzunS, KozumplikO, JakovljevićM, SedićB. Side Effects of Treatment with Benzodiazepines. Psychiatr Danub.2010;22(1):90–93.
40.
LakhanSE, KirchgessnerA. Prescription Stimulants in Individuals with and Without Attention Deficit Hyperactivity Disorder: Misuse, Cognitive Impact, and Adverse Effects. Brain Behav.2012;2(5):661–677.
41.
DowellD, HaegerichTM, ChouR. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA.2016;315(15):1624–1645.
42.
GourlayDL, HeitHA, AlmahreziA. Universal Precautions in Pain Medicine: A Rational Approach to the Treatment of Chronic Pain. Pain Med.2005;6(2):107–112.
43.
KumpferKL, AlvaradoR, WhitesideHO. Family-Based Interventions for Substance Use and Misuse Prevention. Subst Use Misuse.2003;38(11–13):1759–1787.
National Institute on Alcohol Abuse, Alcoholism (US). Helping Patients Who Drink Too Much, A Clinician's Guide. Bethesda, MD: National Institutes of Health; 2007. NIH Publication No. 07-3769. Revised July 2016.
Committee on Substance Abuse. Substance Use Screening, Brief Intervention, and Referral to Treatment for Pediatricians. Pediatrics2011;128(5):e1330–e1340.
48.
BaborTF, Higgins-BiddleJC, HigginsPS, GassmanRA, GouldBE. Training Medical Providers to Conduct Alcohol Screening and Brief Interventions. Subst Abus.2004;25(1):17–26.
49.
DucharmeLJ, ChandlerRK, HarrisAH. Implementing Effective Substance Abuse Treatments in General Medical Settings: Mapping the Research Terrain. J Subst Abus Treat.2016;60:110–118.
50.
KanerEF, BeyerF, DickinsonHO, et al. Effectiveness of Brief Alcohol Interventions in Primary Care Populations. Cochrane Database Syst Rev.2007;(2):CD004148.
51.
GelbergL, AndersenRM, AfifiAA, . Project QUIT (Quit Using Drugs Intervention Trial): A Randomized Controlled Trial of a Primary Care‐Based Multi‐Component Brief Intervention to Reduce Risky Drug Use. Addiction.2015;110(11):1777–1790.
JonasDE, AmickHR, FeltnerC, . Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings: A Systematic Review and Meta-analysis. JAMA.2014;311(18):1889–1900.
FordC, EnglishA, SigmanG. Center for Adolescent Health & the Law. Confidential Health Care for Adolescents: Position Paper of the Society for Adolescent Medicine. J Adolesc Health.2004;35(2):160–167.
58.
DumitrascuCI, MannesPZ, GambleLJ, SelzerJA. Substance Use Among Physicians and Medical Students. Med Student Res J.2014;3:26–35.
59.
KeyesKM, CerdáM, BradyJE, HavensJR, GaleaS. Understanding the Rural–Urban Differences in Nonmedical Prescription Opioid Use and Abuse in the United States. Am J Public Health.2014;104(2):e52–e59.
LevyS, ShrierL, Massachusetts Department of Public Health Bureau of Substance Abuse Services, Massachusetts Department of Mental Health Division of Child and Adolescent Services, Massachusetts Child Psychiatry Access Project. Adolescent SBIRT Toolkit for Providers. Boston, MA: Massachusetts Department of Public Health; 2015.
Center for Substance Abuse Treatment.Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06-4131. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2006.
65.
KorthuisPT, McCartyD, WeimerM, . Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Ann Intern Med.2017;166(4):268–278.